zoom_in
Sale 
MDMB-CHMINACA
218.86$ – 2,342.34$
MDMB-CHMINACA is a Fifth Schedule of the Misuse of Drugs Act (MDA) controlled substance in Singapore as of May 2015
Description
MDMB-CHMINACA (also known as MDMB(N)-CHM) is an indazole-based synthetic cannabinoid that acts as a potent agonist of the CB1 receptor, and has been sold online as a designer drug. It was invented by Pfizer in 2008, and is one of the most potent cannabinoid agonists known, with a binding affinity of 0.0944 nM at CB1, and an EC50 of 0.330 nM. It is closely related to MDMB-FUBINACA, which caused at least 1000 hospitalizations and 40 deaths in Russia as consequence of intoxication
Additional Information
| Product name | |
|---|---|
| Chemical Name | N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl-L-valine |
| CAS | 1185888-32-7 |
| ChemSpider Number | 32055574 |
| PubChem CID | 121491808 |
| Formula | C22H31N3O3 |
| Molar mass | 385.51 g·mol−1 |
| Purity | ≥ 99% |
| Stability | 2 Years |
| Storage | -20° |
person By Robert access_time Published on
Excellent seller – fast shipping, well packed, very pure. Thank you!